Cite
HARVARD Citation
Bader, M. et al. (2021). High-Dose Oral Vancomycin for Treatment of Clostridioides difficile Is Associated With High Risk of Subsequent Cultures With Gram-Negative Organisms. Infectious diseases in clinical practice. 29 (6), p. . [Online].